441
Participants
Start Date
June 30, 2004
Primary Completion Date
August 31, 2005
Study Completion Date
August 31, 2005
solifenacin succinate
Oral
New York
Brooklyn
Garden City
Bay Shore
Albany
Albany
Albany
Lewiston
Williamsville
Monroeville
Pittsburgh
Bethlehem
Allentown
Sellersville
Media
Philadelphia
Philadelphia
Philadelphia
Charleston
Washington D.C.
Garrison
Baltimore
Alexandria
Richmond
Huntington
Cary
Concord
Hickory
Charleston
Myrtle Beach
Aiken
Alpharetta
Atlanta
Blue Ridge
Saint Augustine
Daytona Beach
Tallahassee
Gainesville
Orange City
Orlando
Margate
Aventura
Clearwater
Clearwater
New Port Richey
Jefferson City
Cleveland
Cincinnati
Cincinnati
Indianapolis
Jeffersonville
Muncie
Evansville
Madison
Chicago
Niles
Kankakee
Centralia
St Louis
St Louis
Little Rock
Bethany
Tulsa
Carrollton
Athens
Arlington
Houston
San Antonio
Aurora
Denver
Denver
Boise
Coeur d'Alene
Bountiful
Layton
Ogden
Phoenix
Scottsdale
Albuquerque
Las Vegas
Los Angeles
Los Angeles
Los Angeles
Torrance
Mission Hills
Valley Village
Glendora
Upland
La Mesa
San Bernadino
Dinuba
Modesto
Springfield
Seattle
Spokane
Anchorage
Farmington
Norwalk
Trumbull
Waterbury
Edison
Lawrenceville
Neptune City
West Orange
Lead Sponsor
Astellas Pharma Inc
INDUSTRY